Endocyte Pops on Merck Deal - Presented by: The Aol. On Network

04/16/12 Endocyte shares posted a triple-digit percentage gain after entering into an agreement with Merck & Co. The development deal for Endocyte's experimental cancer drug could bring an additional $880 million to the biopharmaceutical company in m



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
ALTR $ 51.68 2.83 ▲ 5.79%
BAC $ 16.55 0.05 ▲ 0.30%
INTC $ 33.905 0.56 ▼ 1.61%
ONTY $ 3.96 0.54 ▲ 15.79%
GE $ 27.28 0.01 ▲ 0.04%
VALE $ 6.29 0.01 ▼ 0.16%
AAPL $ 130.535 0.26 ▲ 0.20%
BRCM $ 55.465 1.39 ▼ 2.44%

As of 6/1/2015, 04:15 PM

Latest News Headlines

View All Latest Headlines